Community

Common pattern: someone reports huge benefits from peptide X. They also changed sleep, training, diet, stress, and started tracking. Reverse causation and confounding eat almost any 'I felt amazing' anecdote. n=1 with no controls ≠ evidence.

Quick checklist I use: (1) is it human? (2) what was the sample size? (3) was it blinded? (4) industry-funded? (5) primary endpoint pre-registered or moved? (6) replicated? (7) published in peer-reviewed journal or preprint only?

Thymosin Alpha-1 is approved in some countries for hepatitis B and as an immunomodulator. US data is mostly Phase 2 / oncology adjuvant. Frequently discussed for general 'immune support' — that's a stretch from the actual data.

BPC-157 has compelling rodent data on tendon/ligament/gut healing, but I cannot find a single published Phase 1 RCT in humans. Almost all human reports are anecdotal. The compound is also unscheduled and unregulated, so quality control is a real issue. I'd love to see a coordinated patient registry — anyone aware of one?

If you're considering semaglutide or tirzepatide, here are evidence-based questions worth asking: (1) baseline labs you'd recommend? (2) what's our titration plan? (3) when do we re-evaluate? (4) plan if I stop — managed taper vs cold turkey? (5) interactions with my current meds?

I usually start with `peptide-name AND review[pt]` and filter by date >=2020. What do you do?

I usually start with `peptide-name AND review[pt]` and filter by date >=2020. What do you do?

I usually start with `peptide-name AND review[pt]` and filter by date >=2020. What do you do?